COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice
Junqi Ma, Huoying Chen, Yunyi He, Yuye Huang, Xianlong Duan, Qiliang Liu, Zheng Liu, Hongbo Liu · 2026
Read COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice by Junqi Ma, Huoying Chen, Yunyi He, Yuye Huang, Xianlong Duan, Qiliang Liu, Zheng Liu, Hongbo Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13275721.txt.
Description
Junqi Ma and colleagues review COVID-19 mRNA vaccines and their future direction in a 2026 article. The pandemic turned mRNA from an experimental idea into a proven vaccine platform. First products in fatty nanoparticle carriers protected strongly against severe disease.
Protection against infection faded over time, and new variants partly escaped vaccine defences. Mucosal immunity in the nose and throat stayed limited, and responses differed in groups such as older adults. The review covers immune markers, repeated dosing questions, and new RNA formats such as self-amplifying RNA. It closes with uses beyond COVID-19, from other respiratory viruses to cancer therapy.
Catalog record
| CREATOR | Junqi Ma, Huoying Chen, Yunyi He, Yuye Huang, Xianlong Duan, Qiliang Liu, Zheng Liu, Hongbo Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |